Back to Browse Journals

Hypoxia


Prof. Dr. Katschinski

Institute of Cardiovascular Physiology, Georg August University Göttingen, Germany

Prof. Dr. Katschinski

Editor-in-Chief: Professor Doerthe Katschinski

Dr Katschinski is a professor of physiology and director of the Institute of Cardiovascular Physiology at the Georg-August University Göttingen, Germany.

Dr Katschinski is a graduate of the University of Lübeck and received her MD and PD in physiology from the medical faculty. She completed her residency in oncology in Lübeck and a fellowship at the Comprehensive Cancer Center, University Wisconsin, USA. Subsequently, she specialized in physiology. Since 2006 Dr Katschinski has been a member of the medical faculty of the University of Göttingen. She is serving as the vice director of the Heart Center, Göttingen, and she is co-chairing the European HypoxiaNet COST Action, a platform that coordinates and strengthens basic research on hypoxia signalling pathways, accelerating scientific progress on the levels of basic science, technology, pharmacology and translational medicine.

In her research she focuses on a detailed understanding of the mechanisms of hypoxia sensing, signalling and adaptation to exploit this signalling pathway for therapeutic applications in cardiovascular medicine and oncology. Insufficient tissue oxygenation (hypoxia) occurs in a wide range of physiological and pathological conditions, including embryonic development, wound healing, anemia, inflammation, cancer, and ischemic diseases such as infarction and stroke


Prof. Dr. Wenger

Institute of Physiology, University of Zurich, Switzerland

Prof. Dr. Wenger

Associate Editor: Professor Roland Wenger

Dr Wenger is a professor of physiology and director of the Institute of Physiology at the University of Zürich, Switzerland. He graduated in chemistry and received his diploma in biochemistry (1987) and PhD in molecular biology (1990) from the University of Bern (Switzerland). Following a post-doctoral fellowship of the Max-Planck-Society at the Max-Planck-Institute for Immunobiology (Freiburg, Germany) from 1990 to 1993, he became senior scientist at the Institute of Physiology, University of Zürich, where he habilitated and obtained his PD in Physiology (1999). He was university lecturer at the University of Lübeck, Germany until 2001 and associate professor at the University of Leipzig, Germany until 2003, before he became full professor of physiology at the University of Zürich. He has been a member of the medical faculty since 2003 and of the Faculty of Science since 2004 of the University of Zürich, and was vice dean of the medical faculty from 2007-2012.

Dr Wenger chaired the HypoxiaNet COST Action of the European Community (2009-2013) and is a management committee member of the COST Action Gasotransmitters since 2013. He is associate editor of BMC Physiology and editorial advisor of the Biochemical Journal. Dr Wenger heads the Cellular Oxygen Physiology research group which explores the molecular mechanisms and therapeutical consequences of cellular sensing, signalling and adaptation to changing oxygen availability.


Dr Evans

Department of Pharmacology, University of Illinois at Chicago, United States

Dr Evans

Launch Editor: Dr Colin Evans

Dr Evans obtained a BSc in Exercise Sciences from the University of Birmingham (2004-2006) and a PhD in Cardiovascular Medicine from King’s College London (2007-2010). His postdoctoral training was carried out with Prof Randall Johnson at the University of California San Diego and subsequently at the University of Cambridge (2011-2015). In 2016, Dr Evans was awarded a Parke Davis Fellowship by the University of Cambridge to continue his research as Visiting Scholar in the Center for Lung and Vascular Biology at the University of Illinois at Chicago. Dr Evans studies mechanisms that regulate the associations between hypoxia, thrombosis, and inflammatory vascular diseases. His sources of funding have included the British Heart Foundation, the British Society for Haematology, and Thrombosis UK. 


Editorial Board

Till Acker, Professor of Neuropathology, Institute of Neuropathology, University of Giessen, Germany

Aida Bairam, Professor, Department of Pediatrics and Neonatology, Laval University, Canada

Gaetano Cairo, Professor of General Pathology, University of Milan, Italy

Yihai Cao, Professor, Department of Microbiology and Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

William K. Chan, Department Chair and Professor, Department of Pharmaceutics & Medicinal Chemistry , Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific Stockton, CA, USA

Sean Colgan, Professor of Molecular Biology, University of Colorado School of Medicine, Colorado, USA

H. Fred Downey, Regents Professor Emeritus, Institute for Cardiovascular and Metabolic Diseases, University of North Texas Health Science Center at Fort Worth, TX, USA

Claire Dubois, Professor, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Canada

Max Gassmann, Chairman, Institute of Veterinary Physiology, Vetsuisse Faculty and Zurich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland

Norberto C. Gonzalez, Professor Emeritus, Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA

Christian Grimm, Professor, Lab of Retinal Cell Biology, Department of Ophthalmology, University Hospital Zurich, Switzerland

Rodrigo Iturriaga, Professor, Faculty of Biological Sciences, P. Catholic University of Chile, Chile

Thomas Kietzmann, Professor of Cell Biochemistry, University of Oulu, Finland

Ho Jeong Kwon, Professor, Department of Biotechnology, Yonsei University, Seoul, South Korea

Wei Li, Professor, University of Southern California, Department of Dermatology and the USC/Norris Cancer Research Center, Los Angeles, CA, USA

Jose Lopez-Barneo, Professor of Physiology and Director of the Institute of Biomedicine of Seville, Seville, Spain

Eugenia B. Manukhina, Professor and Head, Laboratory of Regulatory Mechanisms of Stress and Adaptation, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow, Russia.

Johanna Myllyharju, Professor of Molecular Biology, Scientific Director of Biocenter Oulu, Oulu Center for Cell-Matrix Research, Biocenter Oulu and Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland

Ken D. O’Halloran, Professor & Chair, Department of Physiology, School of Medicine, Western Gateway Building, Western Road, University College Cork, Ireland

Asher Ornoy, Professor of Anatomy, Embryology and Teratology, Hebrew University Hadassah Medical School, Israel

Silvia Pastorekova, Professor, Head of the Department of Tumor Biology and Director of the Biomedical Research Center, Slovak Academy of Sciences, Slovak Republic.

Dan Peet, Associate Professor, Biochemistry; Head of Hypoxic Signaling Laboratory, School of Biological Sciences, University of Adelaide, Australia

George Perry, Dean, College of Sciences, University of Texas at San Antonio, San Antonio, TX, USA

Kota V. Ramana, Professor, Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA

Professor Sir Peter Ratcliffe FRS is the Director of the Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, and also the Head of Clinical Research at the Francis Crick Institute, London. He is member of the Ludwig Institute for Cancer Research.

Olga V. Razorenova, Assistant Professor, Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA, USA

Jean-Paul Richalet, Professor of Physiology at Université Paris 13, Paris, France

Darren Richard, Professor, Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University, Quebec, Canada

Patrick Ronaldson, Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA

M. Celeste Simon, Ph.D., Scientific Director and Investigator, Abramson Family Cancer Research Institute; Arthur H. Rubenstein, MBBCh Professor, Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

Georgios Simos, Professor of Biochemistry, School of Medicine, University of Thessaly, Larissa, Greece

Pablo Wappner, Professor of Cell and Developmental Biology, Instituto Leloir and School of Sciences, University of Buenos Aires, Argentina

Moira Whyte, Sir John Crofton Professor of Respiratory Medicine and Head of Edinburgh Medical School; Director of the MRC/UoE Centre for Inflammation Research, The University of Edinburgh, The Queen’s Medical Research Institute, Edinburgh, UK